The Hepatitis C Transplant Collaborative
Recruiting · NCT04493385 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Recipient of a proven HCV NAT+ donor heart.
- Re-transplant patients will be included.
Exclusion criteria
- \. Multi-organ transplantation
Where it is running
1 location listed across 1 US state.
- Baylor Scott & White Health Research Institute - Dallas, Texas, United States